arrow
T

Tomoya Fukui

Institute of Science Tokyo
H指数:19
被引数:1,585

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictors of Pre- and Postoperative Quality of Life and Overall Survival in Patients with Non-Small Cell Lung Cancer: A Prospective Study

非小细胞肺癌患者术前和术后生活质量及总生存期的预测因素:一项前瞻性研究

Cancers
IF4.4
2026-02-260
OAAI
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression
2025-11-011
PRE
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non–small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102)

阿特珠单抗联合卡铂和nab-紫杉醇组合疗法治疗TTF-1阴性晚期非鳞状非小细胞肺癌:一项多中心、单臂II期试验(F1NE TUNE,LOGiK 2102)

2025-09-120
PREAI
The impact of antibiotic use on ICI plus chemotherapy versus chemotherapy in NSCLC patients with PD-L1 expression of 1% to 49%

PD-L1表达为1%至49%的NSCLC患者中,抗生素使用对ICI联合化疗与化疗的影响

2024-12-010
PRE
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1%to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study

TTF-1表达对PD-L1表达水平为1%至49%的非小细胞肺癌患者预后预测的影响:化疗与化疗免疫治疗的多中心回顾性研究

2024-10-250
OA
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
2024-04-133
OAAI